Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells
- 1 December 2010
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 88 (12), 1172-1180
- https://doi.org/10.1139/y10-097
Abstract
Paclitaxel is an effective chemotherapeutic agent that is widely used for the treatment of several cancers, including breast, ovarian, and non-small-cell lung cancer. Due to its high lipophilicity, paclitaxel is difficult to administer and requires solubilization with Cremophor EL (polyethoxylated castor oil) and ethanol, which often lead to adverse side effects, including life-threatening anaphylaxis. Incorporation of paclitaxel in dimyristoylphosphatidylcholine:dimyristoylphosphatidylglycerol (DPPC:DMPG) liposomes can facilitate its delivery to cancer cells and eliminate the adverse reactions associated with the Cremophor EL vehicle. Accordingly, the effectiveness of liposomal paclitaxel on MCF-7 breast cancer cells was examined. The results from this study showed that (i) the lipid components of the liposomal formulation were nontoxic, (ii) the cytotoxic effects of liposomal paclitaxel were improved when compared with those seen with conventional paclitaxel, and (iii) the intracellular paclitaxel levels were higher in MCF-7 cells treated with the liposomal paclitaxel formulation. The results of these studies showed that delivery of paclitaxel as a liposomal formulation could be a promising strategy for enhancing its chemotherapeutic effects.Keywords
This publication has 29 references indexed in Scilit:
- Improved biochemical strategies for targeted delivery of taxoidsBioorganic & Medicinal Chemistry, 2007
- Determination of paclitaxel in human and rat blood samples after administration of low dose paclitaxel by HPLC‐UV detectionBiomedical Chromatography, 2007
- Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicinesJournal of Drug Targeting, 2007
- Paclitaxel Repackaged in an Albumin-Stabilized Nanoparticle: Handy or Just a Dandy?Journal of Clinical Oncology, 2005
- Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural FluidsClinical Cancer Research, 2005
- Pharmacological Effects of Formulation VehiclesClinical Pharmacokinetics, 2003
- Weekly administration of paclitaxel: theoretical and clinical basisCritical Reviews in Oncology/Hematology, 2002
- Flow cytometric analysis of the cell cycle phase specificity of DNA damage induced by radiation, hydrogen peroxide and doxorubicinCarcinogenesis: Integrative Cancer Research, 2002
- Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1Oncogene, 2000
- Lung SurfactantEnvironmental Health Perspectives, 1984